Products

Lincomycin Hydrochloride Tablets Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions

    • Product Name: Lincomycin Hydrochloride Tablets Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions
    • Alias: Lincomycin HCl
    • Einecs: 246-036-1
    • Mininmum Order: 1 g
    • Factroy Site: Yudu County, Ganzhou, Jiangxi, China
    • Price Inquiry: admin@ascent-chem.com
    • Manufacturer: Ascent Petrochem Holdings Co., Limited
    • CONTACT NOW
    Specifications

    HS Code

    902432

    Product Name Lincomycin Hydrochloride Tablets Veterinary Grade API
    Chemical Formula C18H34ClN2O6S·HCl
    Appearance White to off-white crystalline powder
    Application Veterinary use in tablets, injections, capsules, powders, granules, premix, and solutions
    Active Ingredient Content Typically 98% or higher
    Solubility Freely soluble in water
    Mechanism Of Action Inhibits bacterial protein synthesis
    Shelf Life 24 to 36 months under proper storage
    Storage Conditions Store in a cool, dry place away from light
    Cas Number 859-18-7

    As an accredited Lincomycin Hydrochloride Tablets Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing White, sealed HDPE bottle containing 1000 tablets, labeled "Lincomycin Hydrochloride Tablets Veterinary Grade API" with dosage, batch number, and expiry date.
    Shipping Lincomycin Hydrochloride Tablets, Veterinary Grade API, are securely packed in moisture-proof, tamper-evident containers, then shipped in sturdy cartons. Shipments are handled by trusted couriers via air or sea freight with temperature and humidity controls as required, ensuring product integrity from dispatch to delivery at your specified destination.
    Storage Lincomycin Hydrochloride Tablets (Veterinary Grade API) should be stored in a tightly closed container, protected from light and moisture. Store at a temperature below 25°C (77°F). Keep away from incompatible substances and in a well-ventilated, dry area. Ensure the product is kept out of reach of animals and unauthorized personnel, following all applicable regulatory guidelines.
    Application of Lincomycin Hydrochloride Tablets Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions

    Purity 99%: Lincomycin Hydrochloride Tablets Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with purity 99% is used in high-potency veterinary formulations, where it ensures maximal antimicrobial efficacy against Gram-positive bacteria.

    Solubility 30 mg/mL: Lincomycin Hydrochloride Tablets Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with solubility 30 mg/mL is used in injectable veterinary solutions, where it provides rapid therapeutic plasma concentrations.

    Particle Size D90<10 μm: Lincomycin Hydrochloride Tablets Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with particle size D90<10 μm is used in oral powder and granule formulations, where it enhances uniform dispersion and consistent dosing.

    Stability at 40°C: Lincomycin Hydrochloride Tablets Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with stability at 40°C is used in premix veterinary feeds, where it ensures shelf-life integrity under high-temperature storage conditions.

    Moisture Content <2%: Lincomycin Hydrochloride Tablets Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with moisture content <2% is used in tablet compression processes, where it minimizes degradation risk and maintains active ingredient potency.

    Assay ≥98.5%: Lincomycin Hydrochloride Tablets Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with assay ≥98.5% is used in the manufacture of veterinary capsules, where it guarantees consistent therapeutic dosage per unit.

    Bulk Density 0.4-0.6 g/mL: Lincomycin Hydrochloride Tablets Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with bulk density 0.4-0.6 g/mL is used for powder premixes, where it provides optimal flow during mixing and filling operations.

    Melting Point 150–152°C: Lincomycin Hydrochloride Tablets Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with melting point 150–152°C is used in granule production, where it remains physically stable during processing.

    Free Quote

    Competitive Lincomycin Hydrochloride Tablets Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615365186327

    Email: admin@ascent-chem.com

    Get Free Quote of Ascent Petrochem Holdings Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Lincomycin Hydrochloride Tablets: Veterinary Grade API for Multiple Applications

    Unlocking Practical Solutions for Animal Health

    Lincomycin Hydrochloride has made its mark as a trusted antibiotic for livestock and poultry. Over years of hands-on production experience, our team has seen firsthand how access to consistent, high-quality active pharmaceutical ingredient (API) makes all the difference for medicine manufacturers and finished-dosage formulators. When the feedlots phone us in the middle of a respiratory disease outbreak looking for reassurance about product origins and batch reliability, we know they are counting on roots that trace directly to our reactors—not some anonymous blend mixed on a loading dock. Building that trust takes real commitment in both technology and raw material traceability.

    Our Lincomycin Hydrochloride Tablets, graded specifically for veterinary use, open doors for veterinarians, feed mill operators, and pharmaceutical formulators who refuse to take risks in animal health protection. The API we offer finds its way into tablets, injectable solutions, capsules, oral powders, granules for inclusion in feed, premixes for broad dosing, and water-soluble forms tailored to different farm needs. Each format comes with its own production challenges, often dictated by the nuances of livestock application and how the intended users handle medicine in real-world farm settings.

    Understanding API Model and Specifications from a Manufacturer’s View

    Since shifting from batchwise to progressively more automated continuous processes, we have responded to demand for particle-size uniformity, moisture stability, and flow consistency in Lincomycin Hydrochloride. Buyers in the veterinary arena do not want surprises in tableting performance or solubility, so models with finer mesh and lower residual solvents get requested for tablets and solutions, while broader cuts go into feed premixes. Each lot we produce undergoes sampling at multiple process stages—not only at final drum packing—because the people formulating powder doses or water-dispersible products judge us by batch-to-batch reliability.

    Our tablets use a tightly controlled Lincomycin Hydrochloride API with purity benchmarks defined by current pharmacopoeia and a residue solvent profile well below regulatory expectations. Analysts operating GC, HPLC, and moisture test instruments live the reality of these standards every day—not because auditors demand it, but because the consequences for animals are real. Setting specifications that work in the hands of tableting operators, encapsulation engineers, or veterinarians preparing injections means attention to both controlled impurity markers and practical flow properties, so the medicine reaches animals as intended.

    The Realities Behind Large-Scale Production

    Tablets must take the rigors of long shipping distances and sometimes erratic farm storage conditions. Over the years, we've adjusted synthesis and downstream processing, aiming for an API that resists caking and clumping under reasonable warehouse humidity. Mixing chemists remember batches from the early days that failed to hold up in rugged livestock environments, leading to dosing inconsistencies and product recalls. Now, each lot gets monitored in simulated storage cycles before shipping, so veterinarians and feed integrators receive a product built for challenging farm conditions, not just for display in a quality control lab.

    Application specialists consult frequently with the downstream manufacturers building granules or water-dispersible powders with our API. They notice if a lot yields cloudy suspensions or sticks during sachet packing—that feedback shapes our continuous improvement. Lincomycin Hydrochloride isn’t simply an ingredient; it determines whether an animal receives the right amount of medicine in a stress event, how long a finished tablet lasts in inventory, and how hard it is for a veterinarian to train staff on proper dosing. These lessons have shaped our technical decisions on refining, drying, particle treatment, and in-process controls right here at our site.

    Animal health as a category demands relentless consistency. Unlike some bulk chemical markets with looser requirements, veterinary products bring urgency during animal health crises and immense responsibility for food safety. Conscientious formulation partners insist on supplier declarations, transparent change control, and thorough batch documentation because the ultimate judge is the animal—not an inspector. By putting controls throughout the entire synthesis route and auditing raw material suppliers, we help producers of veterinary drugs eliminate surprises downstream where a recall or failed therapy can have economic and ethical fallout.

    How Application Dictates Choice of Format

    Lincomycin Hydrochloride does not work as a one-size-fits-all solution. Small tablets offer ease of dosing in poultry and swine, suiting farm routines where treating water or feed on a group scale runs into accuracy issues. For acute infections or outbreak scenarios with fast-moving bacterial threats, veterinary injectable solutions built on our API allow direct bloodstream delivery and assured dosing—a critical tool for veterinarians handling valuable breeding stock or show animals. Water-soluble powders made with our API appeal in broiler or layer houses, simplifying treatment across thousands of birds when labor for individual dosing runs thin.

    Formulators lean on our API’s compressibility and solubility balance to minimize bulking agents and keep doses precise. Some ask for specially milled material for use in gelatin capsules when oral bioavailability becomes a front-line concern, such as in pets or neonatal animals. Over time, feedback from premix houses has prompted us to offer both micronized and standard mesh models so pelleting and mixing performance meet the needs of diverse farm systems. Maintaining a close loop with product developers and monitoring field returns, our production chemists adjust drying and blend times, fine-tuning the product after each commercial application cycle.

    What Stands Apart—Manufacturer’s Reflections

    Third-party traders often gloss over the importance of full traceability that only the original manufacturer can offer. We maintain process journals, from the input of raw fermentation broth all the way to drum packaging. This system allows our regular buyers to verify lot traceability in real-world events—whether a customer suspects contamination, or simply tracks a formulation challenge back to a certain batch. When veterinary regulators request qualification work, direct dialogue and batch provenance matter much more than product catalog promises. Downstream buyers report that working with direct manufacturers can mean the difference between immediate access to essential certificates and long lead time negotiations for missing data.

    A factory that can adjust the process also shortens response time when global antibiotic regulation changes or downstream tablet producers need tighter impurity controls. Our team’s experience with multi-ton batches and the pattern of regulatory audits equips us to adapt quickly—sometimes mid-campaign—so no animal goes untreated during a disease wave. Batch failures, dust issues in dosing areas, or any adverse stability report from the field have prompted real on-site changes that third-party traders can only “report up the chain.” At this stage, our seasoned operators have come to expect field-level feedback resulting in real, actionable process improvements.

    Safety, Compliance, and Practical Experience

    Manufacturing APIs always requires compliance with stringent safety and environmental norms. On the production floor, operators monitor emission systems, wastewater, and occupational exposures, knowing both regulatory authorities and downstream customers care deeply about the outcomes. Failure to control for even minor impurities or skipping batch validation steps brings direct consequences: batch recalls, regulatory penalties, and, most critically, the risk of substandard animal care. Lincomycin Hydrochloride manufacturers who cut corners either disappear from the market or face strict quarantines, impacting supply chains for veterinary products in entire regions.

    Over time, investing in more precise process control systems and batch tracking software has not just improved yields and documentation. It has created confidence in buyers navigating international audits, reshuffled supply chains, and experienced regulatory changes. Documentation packages we prepare reflect not template promises, but the reality of every batch shipped from our doors, down to the environmental controls and active staff signatures. This depth of provenance results in lower downstream failure rates, improved dosing fidelity, and more predictable therapeutic outcomes on the farm.

    What Differentiates Our Lincomycin Hydrochloride From the Crowd

    What often separates manufacturer-sourced API from repackaged material on the open market is the depth of process control and customer accountability. Being a long-term supplier across multiple geographies means we track changes not just in official regulations, but in how animals respond to treatments deployed under harsh field conditions—high summer heat, poor water quality, or unfamiliar feed blends. Every change in process is validated with end-user realities in mind, not theory. Field veterinarians relay data from treatment groups, offering feedback about residue clearances, side reactions, or material handling in farm environments that influence our process engineering decisions.

    Unlike resellers who divert bulk API through untraceable intermediaries, factories such as ours retain full control of synthetic pathways, impurity markers, storage protocols, and batch history. Production engineers test for grind profiles ideal for both fine-tablet and bulk granule applications. Mixing team leads test solubility in the actual water sources livestock drink. These differences materialize on the farm in the form of easier reconstitution, fewer dust plumes in granule-supplemented feed, and tablets that break only when intended. Customers often comment that Lincomycin Hydrochloride sourced directly from original manufacturers results in more reliable, animal-friendly medicine, especially when a disease outbreak hits remote or large-scale farms where logistics are tricky.

    Solving Real Problems for the Veterinary Medicine Industry

    The veterinary field consistently brings tough, honest feedback. Tablet disintegration rates, granule dusting issues in automated feeders, and even how “sticky” an API batch feels under high humidity—our product’s journey doesn’t end at dispatch. By building active feedback loops with major pharmaceutical companies and field veterinarians, we refine our Lincomycin Hydrochloride production in ways that benefit not just chemistry teams, but real animals under stress.

    Through years of handling recalls in regions with severe weather swings, we learned to run simulated shelf-life and field-use stability studies alongside each major process update. Farm partners share photos and notes from the field, sometimes flagging lot-specific quirks before they grow into service issues. Bringing in experts from feed mills and veterinary clinics for hands-on workshops led us to develop formats and packaging more suited to dusty, humid barn conditions and challenge doses in large livestock. This partnership-oriented development stands apart from the blind batch selling in commodity markets.

    Continuous Improvement Rooted in Daily Experience

    The journey of Lincomycin Hydrochloride has not been set-and-forget. Regular feedback from premix factories, water-soluble powder packers, and veterinary clinics has revealed small details that make or break a product’s usefulness in practice. Operators tracking high ambient humidity challenges need APIs that don’t cake in storage, while tableting lines in pharma plants need compressibility without extra additives. Some applications require tailor-made particle sizes for inclusion in liquid injectables, resolved through ongoing process adaptation.

    We have invested in more granular process control—detailed temperature logging has cut down formation of trace degradants, and real-time inline sensors spot batch drift before out-of-spec lots develop. Instead of scaling a single production protocol blindly, our team learns and adjusts, taking input from all levels of the supply chain, even when that means returning to the drawing board after an issue surfaces in the field. Improving what goes into the package and what reaches the animal motivates us daily.

    Supporting Sustainable and Responsible Animal Health

    As consumer priorities and regulatory climates shift globally, animal health product manufacturers face rising demands for transparency, traceability, and ethical stewardship. By manufacturing Lincomycin Hydrochloride from the ground up, we control both the technical backbone and the ethical framing of the substance. This means not just reporting on emissions data or providing transaction records, but being accountable for how the product performs through its entire lifecycle—from lab, to factory, to animal and onward.

    Our approach brings lived experience from the factory floor to the barn aisle. It takes real partnerships across disciplines—chemists, veterinarians, logistics teams, farmers—who each see the medicine from different vantage points. This collaboration helps prevent not only quality incidents, but also waste, time loss, and risks to food security. It’s through this chain of trust and continuous knowledge sharing that Lincomycin Hydrochloride API retains its critical role as a backbone in the fight against animal diseases.

    Lincomycin Hydrochloride Today: Built on History, Ready for Future Challenges

    Manufacturing Lincomycin Hydrochloride API for veterinary use remains both a science and a daily exercise in practical problem-solving. The work forces us out of comfort zones—adapting production to shifting global standards one month, supplying a last-minute batch during a local disease outbreak the next. Every decision, from raw material source selection to final drum sealing, echoes on the farm floor or in the hands of a busy veterinarian. As the original manufacturer, we see these challenges as essential fuel for ongoing improvement—not just in chemistry, but in direct service to those who rely on effective, reliable, and ethical animal medicine every day.

    Top